HomeBWAY • NASDAQ
add
Brainsway ADR Representing 2 Ord Shs
Previous close
$4.93
Day range
$5.00 - $5.18
Year range
$1.38 - $7.62
Market cap
312.48M ILS
Avg Volume
69.15K
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 9.03M | 49.66% |
Operating expense | 6.56M | -24.02% |
Net income | 127.00K | 103.28% |
Net profit margin | 1.41 | 102.20% |
Earnings per share | 0.00 | 100.00% |
EBITDA | 259.00K | 106.51% |
Effective tax rate | 443.24% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 45.98M | -3.35% |
Total assets | 62.97M | -2.33% |
Total liabilities | 21.39M | 12.11% |
Total equity | 41.58M | — |
Shares outstanding | 33.27M | — |
Price to book | 3.95 | — |
Return on assets | 0.75% | — |
Return on capital | 1.10% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 127.00K | 103.28% |
Cash from operations | 2.47M | 210.30% |
Cash from investing | -35.46M | -8,403.51% |
Cash from financing | -527.00K | -621.92% |
Net change in cash | -33.37M | -1,784.42% |
Free cash flow | -115.38K | 96.29% |
About
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem. Wikipedia
CEO
Founded
2003
Headquarters
Website
Employees
134
